Diversity of regulatory T cells to control arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 20, Issue 5, 2006, Pages 897-913

  van Roon, Joel A G ^a   Bijlsma, Johannes W J ^a   Lafeber, Floris P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

arthritis; CD25+ T cells; immunopathology; macrophages; monocytes; regulatory

Indexed keywords

ADALIMUMAB; CD28 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; COLECALCIFEROL; DEXAMETHASONE; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MITOGENIC AGENT; MONOCLONAL ANTIBODY CD3; MYELIN BASIC PROTEIN; SUPERANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; ARTHRITIS; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE RELEASE; DISEASE CONTROL; DRUG TARGETING; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SENSITIZATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ANIMALS; ARTHRITIS; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY;

EID: 33748502760     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2006.06.006     Document Type: Review

References (86)

1. Matzinger P. Tolerance, danger, and the extended family. Annual Review of Immunology 12 (1994) 991-1045
2. van Eden W., van dez Zee R., Taams L.S., et al. Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response. Immunological Reviews 164 (1998) 169-174
3. Chicz R.M., Urban R.G., Gorga J.C., et al. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. The Journal of Experimental Medicine 178 1 (1993) 27-47
4. Burmester G.R., Stuhlmuller B., Keyszer G., and Kinne R.W. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?. Arthritis and Rheumatism 40 1 (1997) 5-18
5. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 3 (1996) 307-310
6. Chabaud M., Durand J.M., Buchs N., et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis and Rheumatism 42 5 (1999) 963-970
7. Morita Y., Yamamura M., Kawashima M., et al. Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis and Rheumatism 41 9 (1998) 1669-1676
8. Namekawa T., Wagner U.G., Goronzy J.J., and Weyand C.M. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis and Rheumatism 41 12 (1998) 2108-2116
9. Roudier J. Association of MHC and rheumatoid arthritis. Association of RA with HLA-DR4: the role of repertoire selection. Arthritis Research 2 3 (2000) 217-220
10. Finnegan A., Mikecz K., Tao P., and Glant T.T. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. Journal of Immunology 163 10 (1999) 5383-5390
11. Seetharaman R., Mora A.L., Nabozny G., et al. Essential role of T cell NF-kappa B activation in collagen-induced arthritis. Journal of Immunology 163 3 (1999) 1577-1583
12. Choy E.H., Pitzalis C., Cauli A., et al. Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens. Arthritis and Rheumatism 39 1 (1996) 52-56
13. Kremer J.M., Westhovens R., Leon M., et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. New England Journal of Medicine 349 20 (2003) 1907-1915
14. Yudoh K., Matsuno H., Nakazawa F., et al. Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis. Arthritis and Rheumatism 43 3 (2000) 617-627
15. Canete J.D., Martinez S.E., Farres J., et al. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Annals of the Rheumatic Diseases 59 4 (2000) 263-268
16. Gratacos J., Collado A., Filella X., et al. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. British Journal of Rheumatology 33 10 (1994) 927-931
17. Simon A.K., Seipelt E., and Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proceedings of the National Academy of Sciences of the USA 91 18 (1994) 8562-8566
18. Dolhain R.J., van der Heiden A.N., ter Haar N.T., et al. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis and Rheumatism 39 12 (1996) 1961-1969
19. McInnes I.B., Leung B.P., Sturrock R.D., et al. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nature Medicine 3 2 (1997) 189-195
20. Morita Y., Yamamura M., Nishida K., et al. Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. Arthritis and Rheumatism 41 2 (1998) 306-314
21. van Roon J.A., Verweij M.C., Wijk M.W., et al. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. Arthritis and Rheumatism 52 6 (2005) 1700-1710
22. Mulherin D., Fitzgerald O., and Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis and Rheumatism 39 1 (1996) 115-124
23. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 423 6937 (2003) 356-361
24. McKenzie B.S., Kastelein R.A., and Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends in Immunology 27 1 (2006) 17-23
25. Park H., Li Z., Yang X.O., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology 6 11 (2005) 1133-1141
26. Andersson A., Kokkola R., Wefer J., et al. Differential macrophage expression of IL-12 and IL-23 upon innate immune activation defines rat autoimmune susceptibility. Journal of Leukocyte Biology 76 6 (2004) 1118-1124
27. Aggarwal S., Ghilardi N., Xie M.H., et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. Journal of Biological Chemistry 278 3 (2003) 1910-1914
28. Taams L.S., van Amelsfort J.M., Tiemessen M.M., et al. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Human Immunology 66 3 (2005) 222-230
29. van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., et al. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis and Rheumatism 50 9 (2004) 2775-2785
30. Firestein G.S., Alvaro-Gracia J.M., Maki R., and Alvaro-Garcia J.M. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. Journal of Immunology 144 9 (1990) 3347-3353
31. Highton J., Carlisle B., and Palmer D.G. Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clinical and Experimental Immunology 102 3 (1995) 541-546
32. Arend W.P., and Dayer J.M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis and Rheumatism 38 2 (1995) 151-160
33. Choy E.H., Isenberg D.A., Garrood T., et al. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis and Rheumatism 46 12 (2002) 3143-3150
34. Feldmann M., and Maini R.N. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?. Annual Review of Immunology 19 (2001) 163-196
35. Tak P.P., Smeets T.J., Daha M.R., et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis and Rheumatism 40 2 (1997) 217-225
36. Brennan F., and Foey A. Cytokine regulation in RA synovial tissue: role of T cell/macrophage contact-dependent interactions. Arthritis Research 4 supplement 3 (2002) S177-S182
37. van Roon J.A., Lafeber F.P., and Bijlsma J.W. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis and Rheumatism 44 1 (2001) 3-12
38. Chen Y., Kuchroo V.K., Inobe J., et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 5176 (1994) 1237-1240
39. Brownlie R.J., Myers L.K., Wooley P.H., et al. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein. Arthritis and Rheumatism 54 3 (2006) 854-863
40. Xu D., Chan W.L., Leung B.P., et al. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. Journal of Experimental Medicine 187 5 (1998) 787-794
41. Verhoef C.M., van Roon J.A., Vianen M.E., et al. Mutual antagonism of rheumatoid arthritis and hay fever; a role for type 1/type 2 T cell balance. Annals of the Rheumatic Diseases 57 5 (1998) 275-280
42. van Roon J.A., and Bijlsma J.W. Th2 mediated regulation in RA and the spondyloarthropathies. Annals of the Rheumatic Diseases 61 11 (2002) 951-954
43. Miossec P., Naviliat M., Dupuy d'Angeac A., et al. Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis. Arthritis and Rheumatism 33 8 (1990) 1180-1187
44. van Roon J.A., van Roy J.L., Gmelig-Meyling F.H., et al. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis and Rheumatism 39 5 (1996) 829-835
45. van Roon J.A., Bijlsma J.W., and Lafeber F.P. Suppression of inflammation and joint destruction in rheumatoid arthritis may require a concerted action of Th2 cytokines. Current Opinion in Investigational Drugs 3 7 (2002) 1011-1016
46. Battaglia M., Gianfrani C., Gregori S., and Roncarolo M.G. IL-10-producing T regulatory type 1 cells and oral tolerance. Annals of the New York Academy of Science 1029 (2004) 142-153
47. Groux H., O'Garra A., Bigler M., et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389 6652 (1997) 737-742
48. Cottrez F., Hurst S.D., Coffman R.L., and Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. Journal of Immunology 165 9 (2000) 4848-4853
49. Lan R.Y., Ansari A.A., Lian Z.X., and Gershwin M.E. Regulatory T cells: development, function and role in autoimmunity. Autoimmunity Reviews 4 6 (2005) 351-363
50. Horwitz D.A., Zheng S.G., Gray J.D., et al. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Seminare in Immunology 16 2 (2004) 135-143
51. Fukaura H., Kent S.C., Pietrusewicz M.J., et al. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. The Journal of Clinical Investigation 98 1 (1996) 70-77
52. Appel H., Neure L., Kuhne M., et al. An elevated level of IL-10- and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis. Clinical Rheumatology 23 5 (2004) 435-440
53. Barnett M.L., Kremer J.M., St Clair E.W., et al. Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis and Rheumatism 41 2 (1998) 290-297
54. Trentham D.E., Dynesius-Trentham R.A., Orav E.J., et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261 5129 (1993) 1727-1730
55. Sakaguchi S., and Sakaguchi N. Regulatory T cells in immunologic self-tolerance and autoimmune disease. International Reviews of Immunology 24 3-4 (2005) 211-226
56. van Amelsfort J.M.R., van Roon J.A.G., Noordegraaf M., et al. Influence of the inflammatory milieu on the suppressive function of CD4+CD25+ regulatory T cells in rheumatoid arthritis. Annals of the Rheumatic Diseases 64 (2005) 521
57. Thornton A.M., and Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. Journal of Experimental Medicine 188 2 (1998) 287-296
58. Taams L.S., Smith J., Rustin M.H., et al. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. European Journal of Immunology 31 4 (2001) 1122-1131
59. Sakaguchi S., Sakaguchi N., Asano M., et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology 155 3 (1995) 1151-1164
60. Valmori D., Merlo A., Souleimanian N.E., et al. A peripheral circulating compartment of natural naive CD4 Tregs. Journal of Clinical Investigation 115 7 (2005) 1953-1962
61. Ruprecht C.R., Gattorno M., Ferlito F., et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. Journal of Experimental Medicine 201 11 (2005) 1793-1803
62. Ehrenstein M.R., Evans J.G., Singh A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. Journal of Experimental Medicine 200 3 (2004) 277-285
63. de Kleer I.M., Wedderburn L.R., Taams L.S., et al. CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. Journal of Immunology 172 10 (2004) 6435-6443
64. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nature Immunology 6 4 (2005) 345-352
65. Walker M.R., Kasprowicz D.J., Gersuk V.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. Journal of Clinical Investigation 112 9 (2003) 1437-1443
66. Morgan M.E., van Bilsen J.H., Bakker A.M., et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Human Immunology 66 1 (2005) 13-20
67. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nature Reviews Immunology 2 6 (2002) 389-400
68. Dieckmann D., Bruett C.H., Ploettner H., et al. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. Journal of Experimental Medicine 196 2 (2002) 247-253
69. Jonuleit H., Schmitt E., Kakirman H., et al. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. Journal of Experimental Medicine 196 2 (2002) 255-260
70. Cederbom L., Hall H., and Ivars F. CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. European Journal of Immunology 30 6 (2000) 1538-1543
71. Misra N., Bayry J., Lacroix-Desmazes S., et al. Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells. Journal of Immunology 172 8 (2004) 4676-4680
72. Morgan M.E., Flierman R., van Duivenvoorde L.M., et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis and Rheumatism 52 7 (2005) 2212-2221
73. Frey O., Petrow P.K., Gajda M., et al. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Research and Therapy 7 2 (2005) R291-R301
74. van Roon J.A., Glaudemans K.A., Bijlsma J.W., and Lafeber F.P. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 62 2 (2003) 113-119
75. George T.C., Bilsborough J., Viney J.L., and Norment A.M. High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell-mediated suppression in vitro. European Journal of Immunology 33 2 (2003) 502-511
76. Zheng Y., Manzotti C.N., Liu M., et al. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. Journal of Immunology 172 5 (2004) 2778-2784
77. Garcia G., Komagata Y., Slavin A.J., et al. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen. Journal of Autoimmunity 13 3 (1999) 315-324
78. Sakkas L.I., Scanzello C., Johanson N., et al. T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis [see comments]. Clinical and Diagnostic Laboratory Immunology 5 4 (1998) 430-437
79. Prakken B.J., Samodal R., Le T.D., et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the USA 101 12 (2004) 4228-4233
80. van Roon J.A., van Eden W., van Roy J.L., et al. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. Journal of Clinical Investigation 100 2 (1997) 459-463
81. Beyersdorf N., Gaupp S., Balbach K., et al. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. Journal of Experimental Medicine 202 3 (2005) 445-455
82. Bisikirska B., Colgan J., Luban J., et al. TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. Journal of Clinical Investigation 115 10 (2005) 2904-2913
83. van Maurik A., Herber M., Wood K.J., and Jones N.D. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. Journal of Immunology 169 10 (2002) 5401-5404
84. Kemper C., Chan A.C., Green J.M., et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421 6921 (2003) 388-392
85. Marshall E. Drug trials. Violent reaction to monoclonal antibody therapy remains a mystery. Science 311 5768 (2006) 1688-1689
86. Zhao D.M., Thornton A.M., DiPaolo R.J., and Shevach E.M. Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107 10 (2006) 3925-3932